BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 19, 2025
Home » Authors » Jim Stommen

Articles by Jim Stommen

As usual, med-tech investing conference spurs networking, ideas

July 1, 2011
By Jim Stommen

Jay Yadav, MD: CEO of CardioMEMS sees gains in noninvasively retrieving vital information from HF patients

July 1, 2011
By Jim Stommen

Life sciences experiencing big-time growth in Indiana

June 30, 2011
By Jim Stommen

Report: Global venture funding requires stronger IPO market

June 27, 2011
By Jim Stommen
Venture capitalists worldwide are dismayed by the current level of initial public offering (IPO) activity, saying the shortage of opportunities to take a company public in turn means a lack of support for a healthy VC industry. (Medical Device Daily)
Read More

Opportunities aplenty in the healthcare space, says report

June 24, 2011
By Jim Stommen
A new report from the global consulting firm PricewaterhouseCoopers (PwC; New York) says that major opportunities are being eyed in the healthcare sector by companies and entrepreneurs alike, drawn by increased spending in a market segment that is seen as a bright spot in an economy that, while clearly on the rebound, remains sluggish overall. (Medical Device Daily)
Read More

New recommendations issued on lab analysis for diabetes

June 23, 2011
By Jim Stommen
A committee formed to review recommendations for the use of laboratory analysis in patients with diabetes issued by the National Academy of Clinical Biochemistry (NACB; Washington) in 2002 has issued updated recommendations. -- (Medical Device Daily)
Read More

Continued M&A activity seen in device sector, says PwC

June 22, 2011
By Jim Stommen

Paulsen slams policies that hold back medical technology

May 27, 2011
By Jim Stommen

Opportunities seen in ortho and neurostimulation spaces

May 26, 2011
By Jim Stommen
MINNEAPOLIS – Two very different med-tech sectors, neurostimulation and orthopedics, were among the device specialty tracks discussed during concurrent sessions that made up the bulk of an afternoon program at the MedTech Investing Conference at the Graves 601 Hotel. (Medical Device Daily)
Read More

Asian markets, especially China, draw interest from attendees

May 25, 2011
By Jim Stommen
MINNEAPOLIS – The Graves 601 Hotel is located in the heart of downtown Minneapolis, with an Irish pub on one flank and the decidedly American Hard Rock Café on the other, but for the better part of an hour, attendees at the 10th annual MedTech Investing Conference were transported – at least in thought – to another part of the world. (Medical Device Daily)
Read More
Previous 1 2 … 7 8 9 10 11 12 13 14 15 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Rare disease illustration

    Rare earth: Biomarin to use global reach post-$4.8B Amicus buy

    BioWorld
    Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing